In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Vaccine mismatches may raise severity risks this flu season. Low vaccination uptake increases overall flu transmission ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

A Centers for Disease Control and Prevention webpage that previously stated "Vaccines do not cause autism" has been changed ...

The agency also approved epcoritamab (Epkinly) with lenalidomide and rituximab for relapsed or refractory follicular lymphoma ...

Study shows high-dose vaccines work better for older adults while cell-based versions benefit younger people as respiratory ...

Among the most commonly cited reasons for COVID vaccine hesitation are fears about side effects, long-term health ...

A new vaccine to protect dairy and poultry workers from bird flu does not require a needle and works against multiple strains ...

More than three-quarters of American adults didn’t get a COVID shot last season, a figure that health care experts warn could ...

A Fredericton-based pharmacist says people are still showing up to get vaccinated for influenza, despite recent news that ...

Flu vaccines are crucial tools in protecting public health by reducing the risk of influenza illness and its complications.

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.